Fertility Genomics

Leveraging genomics insights to address infertility, improve reproductive outcomes, support patient specific tailored interventions, enhance success rates of ART.

Book Counselling
Innovation in Fertility
Innovative Fertility Testing
GeneTech leads with Genomic Fertility Analysis (GeneFeminaTM, GeneAndroTM) and advanced HLA compatibility assessments for precise fertility solutions.
Advanced Embryo Testing
Novel embryo testing methods empower IVF specialists with cutting-edge tools.
AI-Driven Personalization
Data-driven AI provides tailored recommendations to enhance fertility outcomes.
Genetech Expertise
Our expertise in the field of Fertility Medicine includes Reproductive Genomics, Clinical Genetics, Immunogenetics, Molecular Genetics, Prenatal and Pre-implantation Genetics, Cytogenetics, Biochemical Genetics, Epigenetics and Genetic Counselling.
Experience
Handled more than 100,000+ infertility cases since 1998.
Embryo Testing
Expertise in embryo testing: Handled thousands of embryos for PGTA, PGTM or NICS.
Innovation
World’s first launch of Genomic Fertility Analysis with successful adoption by IVF clinics across the country.
Recognition
Multiple research papers on infertility in reputed international scientific journals.
Comprehensive services
Offers most comprehensive services for Fertility clinics.
GeneAndro & GeneFemina For Sucessfull IVF Pregnancy

The comprehensive female and male Genomic Fertility Analysis offers the best possible diagnostic yield through identification of genomic root cause for multiple infertility phenotypes. Provides pharmacogenomic insights and paves way for personalised treatment, leading to enhanced success rate with ART.

Learn more

Talk to your IVF Physician about GeneAndro and GeneFemina

More than 100 IVF clinics across India and overseas routinely use GeneFemina and GeneAndro in their IVF practice, and more than 10,000 couples have benefited from these in the last few years. 



Talk to your IVF physician about this.

Services
Most comprehensive genetic services for infertility - Karyotyping, GeneFeminaTM,  GeneAndroTM, HLA-sharing, AZF, CFTR, Fragile X, Carrier tests, CMA, NIPT, PGT-A, PGT-SR, PGT-M & other molecular tests.
Genetic Counseling
Our genetic counselling services empower patients and families by providing expert guidance on genetic conditi
2 weeks
750
GeneFeminaTM
360 degree coverage of all genetic conditions associated with female infertility, premature ovarian insufficie
2 weeks
20000
HLA Sharing in Couple
High resolution HLA sharing in couple to identify maternal immune response risk caused due to sharing of HLA a
2 weeks
24000
KIR Genotyping
Maternal KIR (Killer cell immunoglobulin-like receptor) genotyping is a test to analyze a woman's genes, which
2 weeks
12000
Factor-V Leiden Mutation
The Factor V Leiden mutation is associated with increased risk of pregnancy loss, particularly recurrent misca
2 weeks
4500
Genetic Counseling
Our genetic counselling services empower patients and families by providing expert guidance on genetic conditi
2 weeks
750
Fragile X Methylation
Fragile X syndrome causes moderate to severe intellectual disability. It mostly affects males and females usua
2 weeks
10000
Fragile X Screening
Fragile X syndrome causes moderate to severe intellectual disability. It mostly affects males and females usua
2 weeks
12000
Genetic Counseling
Our genetic counselling services empower patients and families by providing expert guidance on genetic conditi
2 weeks
750
Non Invasive Chromosomal Screening (NICS) 4 Embryos
Non invasive chromosomal screening is done to identify chromosomal aneuploidy in the embryos using spent media
2 weeks
60000
Non Invasive Chromosomal Screening (NICS) 2 Embryos
Non invasive chromosomal screening is done to identify chromosomal aneuploidy in the embryos using spent media
2 weeks
30000
Non Invasive Chromosomal Screening (NICS) 3 Embryos
Non invasive chromosomal screening is done to identify chromosomal aneuploidy in the embryos using spent media
2 weeks
45000
Alpha Thalassemia Carrier Screening (for COUPLE)
Alpha Thalassemia is caused by impaired production of Alpha globin which is a part of hemoglobin molecule. The
2 weeks
30000
BRCA 1&2 Full Gene Sequencing
Hereditary breast and ovarian cancer (HBOC) risk is elevated in the presence of brca1 and 2 pathogenic gene va
2 weeks
18000
Beta Thalassemia Carrier Screening (for COUPLE)
Beta Thalassemia is caused by reduced or absent synthesis of the beta chains of hemoglobin that result severe
2 weeks
30000
Beta Thalassemia
Beta Thalassemia is caused by reduced or absent synthesis of the beta chains of hemoglobin that result severe
2 weeks
15000
Fertility

Genomics

Leveraging genomics insights to address infertility, improve reproductive outcomes, support patient specific tailored interventions, enhance success rates of ART.

Fertility

Genomics

Leveraging genomics insights to address infertility, improve reproductive outcomes, support patient specific tailored interventions, enhance success rates of ART.

Innovation in Fertility

GeneTech remains at the forefront of fertility genomics with major breakthroughs including Genomic Fertility Analysis (GeneFeminaTM, GeneAndroTM), enhanced HLA compatibility assessments, data driven AI for personalised recommendations, novel embryo testing methods that empower IVF specialists.

Genetech Expertise
Our expertise in the field of Fertility Medicine includes Reproductive Genomics, Clinical Genetics, Immunogenetics, Molecular Genetics, Prenatal and Pre-implantation Genetics, Cytogenetics, Biochemical Genetics, Epigenetics and Genetic Counselling.
Experience
Handled more than 100,000+ infertility cases since 1998.
Embryo Testing
Expertise in embryo testing: Handled thousands of embryos for PGTA, PGTM or NICS.
Innovation
World’s first launch of Genomic Fertility Analysis with successful adoption by IVF clinics across the country.
Recognition
Multiple research papers on infertility in reputed international scientific journals.
Comprehensive services
Offers most comprehensive services for Fertility clinics.

GeneAndro and GeneFemina for Successful IVF Pregnancy

The comprehensive female and male Genomic Fertility Analysis offers the best possible diagnostic yield through identification of genomic root cause for multiple infertility phenotypes. Provides pharmacogenomic insights and paves way for personalised treatment, leading to enhanced success rate with ART.

Talk to your Physician about GeneAndro and GeneFemina

The continuous and increasing adoption of GeneFemina and GeneAndro tests is a testimonial for the new standards set by GeneTech and its commitment to the field of Fertility Genomics.

More than 100 IVF clinics across India and overseas routinely use GeneFemina and GeneAndro in their IVF practice, and more than 10,000 couples have benefited from these in the last few years. 



Talk to your IVF physician about this.

Services
GeneTech is a pioneer in Fertility genetics and genomics offering services to Fertility clinics since 1998. GeneTech’s latest innovations in Fertility Genomics have transformed Fertility Medicine as a practice.
Genetic Counseling
Our genetic counselling services empower patients and families by providing expert guidance on genetic conditions, their risks, and inheritance patterns. Our counsellors assess family medical histories to identify potential genetic risks and explain the benefits and limitations of genetic testing.
750
2 weeks
GeneFeminaTM
360 degree coverage of all genetic conditions associated with female infertility, premature ovarian insufficiency, poor response to controlled ovarian stimulation, poor oocyte quality, fertillization failure, oocute maturation defects, implantation failure, failed IUI, IVF, ICSI, recurrent pregnancy losses. More than 500 genes sequenced and analyed. ART implications, preventive management, pharmacogenomic implications are provided to facilitate patient specific individualised stimulation and treatment. Research shows improvement in IVF sucess rate based on individualised treatment based on GeneFeminaTM results
20000
2 weeks
HLA Sharing in Couple
High resolution HLA sharing in couple to identify maternal immune response risk caused due to sharing of HLA alleles
24000
2 weeks
KIR Genotyping
Maternal KIR (Killer cell immunoglobulin-like receptor) genotyping is a test to analyze a woman's genes, which helps determine the compatibility between her immune cells and the fetus's cells.
12000
2 weeks
Pre Implantation Genetic Testing for Monogenic disorders (PGTM)
Pre implantation genetic testing for monogenic disorders or Single gene mendelian abnormalities is perfomed on embryo biopsy (1 sample) sent to the lab. It is offered to patients with family history of genetic disorders or carrier parents. Will need Genetic Counseing and pre-PGTM work up before offering test on biopsy.
CALL
2 weeks
Pre Implantation Genetic Testing for Aneuploidy (PGTA) 5 Embryos
Pre implantation genetic testing for chromosomal aneuploidy is perfomed on embryo biopsy (1 sample) sent to the lab. It is offered to infertility patients with increased maternal age, history of recurrent pregnancy loss, recurrent IVF failures. Embryo transfer recommendations are provided along with priority score
70000
2 weeks
Pre Implantation Genetic Testing for Aneuploidy (PGTA) 4 Embryos
Pre implantation genetic testing for chromosomal aneuploidy is perfomed on embryo biopsy (1 sample) sent to the lab. It is offered to infertility patients with increased maternal age, history of recurrent pregnancy loss, recurrent IVF failures. Embryo transfer recommendations are provided along with priority score
56000
2 weeks
Pre Implantation Genetic Testing for Aneuploidy (PGTA) 3 Embryos
Pre implantation genetic testing for chromosomal aneuploidy is perfomed on embryo biopsy (1 sample) sent to the lab. It is offered to infertility patients with increased maternal age, history of recurrent pregnancy loss, recurrent IVF failures. Embryo transfer recommendations are provided along with priority score
45000
2 weeks
Pre Implantation Genetic Testing for Aneuploidy (PGTA) 2 Embryos
Pre implantation genetic testing for chromosomal aneuploidy is perfomed on embryo biopsy (1 sample) sent to the lab. It is offered to infertility patients with increased maternal age, history of recurrent pregnancy loss, recurrent IVF failures. Embryo transfer recommendations are provided along with priority score
30000
2 weeks
Pre Implantation Genetic Testing for Aneuploidy (PGTA) 1 Embryo
Pre implantation genetic testing for chromosomal aneuploidy is perfomed on embryo biopsy (1 sample) sent to the lab. It is offered to infertility patients with increased maternal age, history of recurrent pregnancy loss, recurrent IVF failures. Embryo transfer recommendations are provided along with priority score
15000
2 weeks
Peripheral Blood Karyotyping
Chromosomal anlaysis to identify numerical and structural abnormalities of chromosomes associated with growth and development
3500
2 weeks
Parental Karyotyping
Chromosomal analysis of couple to rule out balanced chromosome translocations associated with recurrent pregnancy losses and bad obstetric history. First tier, basic genetic test for couples with bad obstetric history.
6500
2 weeks
Sperm Aneuploidy
Spermwith higher rate of aneuploidy negative impact on pregnancy. The test identifies sperm aneuploidy rates of chromosomes associated with recurrent pregnancy losses and aneuploidy risk for offspring.
7500
2 weeks
Fragile X Methylation
Fragile X syndrome causes moderate to severe intellectual disability. It mostly affects males and females usually have milder symptoms. The test determines methylation in FMR1 gene to diagnose the Fragile X syndrome phenotype or carrier status. Female carriers may exhibit premature ovarian insufficiency.
10000
2 weeks
Fragile X Screening
Fragile X syndrome causes moderate to severe intellectual disability. It mostly affects males and females usually have milder symptoms. The test determines the number of CGG repeats in FMR1 gene to diagnose the Fragile X syndrome phenotype or carrier status. Female carriers may exhibit premature ovarian insufficiency.
12000
2 weeks
NIPT (All Chromosomes)
Non invasive prenatal test is a highly sensitive screening test offered to pregnant women with >10 weeks of gestation to identify risk for chromosomal aneuploidy. The test looks at total or partial aneuploidy of all 46 chromosomes including genetic conditions such as Down syndrome, Edward Syndrome, Patau Syndrome, Turner Syndrome etc. All High risk results must be followed up by Prenatal diagnostic proceedures.
15000
2 weeks
Genetic Counseling
Our genetic counselling services empower patients and families by providing expert guidance on genetic conditions, their risks, and inheritance patterns. Our counsellors assess family medical histories to identify potential genetic risks and explain the benefits and limitations of genetic testing.
750
2 weeks
Non Invasive Chromosomal Screening (NICS) 5 Embryos
Non invasive chromosomal screening is done to identify chromosomal aneuploidy in the embryos using spent media samples (5 samples) sent to the lab. It is offered to infertility patients with increased maternal age, history of recurrent pregnancy loss, recurrent IVF failures. Embryo transfer recommendations are provided along with priority score.
75000
2 weeks
Non Invasive Chromosomal Screening (NICS) 2 Embryos
Non invasive chromosomal screening is done to identify chromosomal aneuploidy in the embryos using spent media samples (2 samples) sent to the lab. It is offered to infertility patients with increased maternal age, history of recurrent pregnancy loss, recurrent IVF failures. Embryo transfer recommendations are provided along with priority score.
30000
2 weeks
Non Invasive Chromosomal Screening (NICS) 3 Embryos
Non invasive chromosomal screening is done to identify chromosomal aneuploidy in the embryos using spent media samples (3 samples) sent to the lab. It is offered to infertility patients with increased maternal age, history of recurrent pregnancy loss, recurrent IVF failures. Embryo transfer recommendations are provided along with priority score.
45000
2 weeks
Non Invasive Chromosomal Screening (NICS) 1 Embryo
Non invasive chromosomal screening is done to identify chromosomal aneuploidy in the embryo using spent media sample (1 sample) sent to the lab. It is offered to infertility patients with increased maternal age, history of recurrent pregnancy loss, recurrent IVF failures. Embryo transfer recommendations are provided along with priority score.
15000
2 weeks
Non Invasive Chromosomal Screening (NICS) 4 Embryos
Non invasive chromosomal screening is done to identify chromosomal aneuploidy in the embryos using spent media samples (4 samples) sent to the lab. It is offered to infertility patients with increased maternal age, history of recurrent pregnancy loss, recurrent IVF failures. Embryo transfer recommendations are provided along with priority score.
60000
2 weeks
Factor-V Leiden Mutation
The Factor V Leiden mutation is associated with increased risk of pregnancy loss, particularly recurrent miscarriages and late-term pregnancy loss. The mutation can lead to an increased risk of blood clots, which may result in placental complications and fetal loss. Testing followed by management options may be considered in high risk patients.
4500
2 weeks
Genetic Counseling
Our genetic counselling services empower patients and families by providing expert guidance on genetic conditions, their risks, and inheritance patterns. Our counsellors assess family medical histories to identify potential genetic risks and explain the benefits and limitations of genetic testing.
750
2 weeks
Fragile X Screening
Fragile X syndrome causes moderate to severe intellectual disability. It mostly affects males and females usually have milder symptoms. The test determines the number of CGG repeats in FMR1 gene to diagnose the Fragile X syndrome phenotype or carrier status. Female carriers may exhibit premature ovarian insufficiency.
12000
2 weeks
Fragile X Methylation
Fragile X syndrome causes moderate to severe intellectual disability. It mostly affects males and females usually have milder symptoms. The test determines methylation in FMR1 gene to diagnose the Fragile X syndrome phenotype or carrier status. Female carriers may exhibit premature ovarian insufficiency.
10000
2 weeks
HLA Sharing in Couple
High resolution HLA sharing in couple to identify maternal immune response risk caused due to sharing of HLA alleles
24000
2 weeks
KIR Genotyping
Maternal KIR (Killer cell immunoglobulin-like receptor) genotyping is a test to analyze a woman's genes, which helps determine the compatibility between her immune cells and the fetus's cells.
12000
2 weeks
Alpha Thalassemia Carrier Screening (for COUPLE)
Alpha Thalassemia is caused by impaired production of Alpha globin which is a part of hemoglobin molecule. The severe type is known as hemoglobin Bart hydrops fetalis syndrome, which is also called Hb Bart syndrome or alpha thalassemia major. The milder form is called HbH disease. The test identifies pathogenic variants of HBA1 and HBA2 genes associated with Alpha Thalassemia phenotype or carrier status
30000
2 weeks
BRCA 1&2 Full Gene Sequencing
Hereditary breast and ovarian cancer (HBOC) risk is elevated in the presence of brca1 and 2 pathogenic gene variants
18000
2 weeks
Beta Thalassemia Carrier Screening (for COUPLE)
Beta Thalassemia is caused by reduced or absent synthesis of the beta chains of hemoglobin that result severe anemia. The test identifies pathogenic variants of beta Globin gene associated with betaThalassemia phenotype or carrier status
30000
2 weeks
Beta Thalassemia
Beta Thalassemia is caused by reduced or absent synthesis of the beta chains of hemoglobin that result severe anemia. The test identifies pathogenic variants of beta Globin gene associated with betaThalassemia phenotype or carrier status
15000
2 weeks
Beta Thalassemia Carrier Screening
Beta Thalassemia is caused by reduced or absent synthesis of the beta chains of hemoglobin that result severe anemia. The test identifies pathogenic variants of beta Globin gene associated with betaThalassemia phenotype or carrier status
15000
2 weeks
Comprehensive Inherited Cancer Gene Panel
Inherited germ line mutations play an important role in cancer risk or predisposition. The test uses next-generation sequencing (NGS) based exome sequencing to analysis hereditary mutations on hundreds of genes that will help in taking preventive measures to reduce the likelihood of developing cancer.
26000
2 weeks
Explore all tests
Patient Stories
Patient Stories

Female Infertility - Poor Oocyte Retrieval

Couple was struggling with multiple IVF failures – 4 IUI, 1 IVF and 2 ICSI. Ovarian induction yielded fewer oocytes with average to poor quality leading to implantation failures. GeneFeminaTM analysis not just identified the root cause of poor response to ovarian stimulation in female partner, but also suggested the best suited protocol for success.

Patient Stories
Patient Stories

Female Infertility Empty Follicle Syndrome

Identification of genetic cause of empty follicle syndrome by GeneFeminaTM not only provided root cause information but also valuable information for clinical management and corresponding treatment.

Patient Stories
Patient Stories

Male infertility issues

Semen analysis of the male partner showed low sperm motility and poor sperm morphology. Multiple IUI procedures did not help. Couple were contemplating whether to go for ICSI, and if yes, with self or donor sperm. GeneAndroTManalysis not only identified the root cause of male infertility but also helped them in decision making.

Patient Stories
Patient Stories

Irregular periods

Early diagnosis of premature ovarian insufficiency by GeneFeminaTM helped in achieving fertility, by taking early decisions on treatment. Cryopreserving embryos helped in avoiding multiple, not so pleasant, induction cycles.

Genetics Expert 

Counselling
GeneTech pioneered genetic testing in India in 1998 and has the most comprehensive range of tests using technologies like Next Generation Sequencing (NGS), Sanger Sequencing, MLPA, Cyto Microarray, SNP arrays, qPCR, PCR, Cytogenetics, FISH, Chemiluminescence, and others.
Book Now
Testimonials
Testimonials from our highly satisfied customers, physicians, patients and research partners in diverse fields highlighting the trust and credibility built over years.
View all
"Praesent commodo cursus magna, vel scelerisque nisl consectetur et. Duis mollis, est non commodo luctus, nisi erat porttitor ligula, eget lacinia odio sem nec elit. Etiam porta sem malesuada magna mollis euismod."
Name Surname
Position, Company name
"1111 Praesent commodo cursus magna, vel scelerisque nisl consectetur et. Duis mollis, est non commodo luctus, nisi erat porttitor ligula, eget lacinia odio sem nec elit. Etiam porta sem malesuada magna mollis euismod."
Name Surname
Position, Company name
"Donec ullamcorper nulla non metus auctor fringilla. Vivamus sagittis lacus vel augue laoreet rutrum faucibus dolor auctor."
Name Surname
Position, Company name
"Aenean lacinia bibendum nulla sed consectetur. Sed posuere consectetur est at lobortis. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras justo odio, dapibus ac facilisis in, egestas eget quam."
Name Surname
Position, Company name
"Donec sed odio dui. Donec id elit non mi porta gravida at eget metus. Aenean lacinia bibendum nulla sed consectetur."
Name Surname
Position, Company name
"Nullam quis risus eget urna mollis ornare vel eu leo. Donec id elit non mi porta gravida at eget metus. Sed posuere consectetur est at lobortis. Praesent commodo cursus magna, vel scelerisque nisl consectetur et."
Name Surname
Position, Company name
"Donec ullamcorper nulla non metus auctor fringilla. Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet risus."
Name Surname
Position, Company name
Dr. Anuradha Udumudi from GeneTech is a brilliant and committed scientist with tremendous command over medical genetics. With her knowledge and dedication, she had made original contribution to research and diagnostics in the area of infertility and reproductive medicine.
Dr. Firuza Parekh
MBBS, MD (ObGyn) DGO, FCPS Infertility Specialist
FertilTree-Jaslok, Mumbai
Genomics fertility analysis allows us to look deep into the genomics and identifies the root cause of infertility and recurrent pregnancy losses. I am now not only able to answer the question “why did this happen” to my patients but I am in a position to guide them better. I congratulate Dr. Anuradha and her team for her passionate and sincere work in this field.
Dr. Vandana Hegde
MBBS, MS (ObGyn) Infertility Specialist, Reproductive Endocrinologist
Hegde Fertility, Hyderabad
I see many patients with recurrent implantation failure and pregnancy loss. Apart from routine screening tests, I use Genomic Fertility Analysis. 100s of genes associated with infertility are sequenced & interpreted. It’s interesting how many couples have single gene defects and how well they are picked up in these genomic panels. Knowing the root genetic cause helps me manage the case and plan my treatment protocols better. The results are very useful in counseling couples.
Dr. Narmada Katkam
MBBS, MD (ObGyn), FRCOG (UK) Infertility Specialist
Genesis Fertility, Hyderabad
Swapna Health Care has been associated with Genetech since a few decades, for all the investigations related to Genetics.They are highly professional, efficient and punctual, and believe in constant updating and upgrading just like us. I am sure our journey together over the decades has benefited many patients. I wish them all the best!
Dr. Savitha Devi
Senior Obstetrician
Swapna Hospital and IVF center, Hyderabad
GeneTech's GeneAndro and GeneFemina are harbingers of the arrival of precision medicine to fertility medicine. I am proud to be an early adopter of this technology, diagnosing risks, modulating treatment protocols based on world’s first comprehensive genomic fertility analysis.
Dr. Nandita Palshetkar
MBBS, MD (ObGyn), FRCOG
Bloom IVF, Mumbai
For a physician, it is very frustrating when we are unable to give reasons for reproductive failures. Genomic panels come very handy as they are very comprehensive and check large number of genes. Not only the results explain the underlying cause for the medical condition but also give management guidance which is very useful in my practice. Patients today want to understand the cause and are happy to follow recommendations to achieve fertility
Urvashi Sehgal
MBBS, MD (ObGyn) Infertility Specialist and ObGyn
Phoenix Hospitals, New Delhi
GeneTech is not only a pioneer of medical genetic testing in the country, but continues to bring the most advanced technologies in helping our practice with diagnosis and management. Our association with GeneTech and Dr. Anuradha Udumudi is for more than two decades. Their service orientation and deep involvement in each and every case helps us give our best to and every patient who needs such services.
Dr. Meena Ugale
MBBS, MD (ObGyn)
Kirloskar Hospital, Hyderabad
Genomic panels developed for infertility, recurrent pregnancy losses and PCOS are able to identify root cause for the conditions like never before. The panels are useful in making critical decisions for patients and families looking forward to have a successful fertility treatment outcome. Adopting the innovative genomic panels will help physicians a great deal specially in treating idiopathic cases. My best wishes to the team and I wish them success.
Dr. Jagdip Shah
MBBS, MD (ObGyn) Infertility specialist
Parakh Hospital, Mumbai
Many of my patients with unexpected poor response in IVF, Recurrent implantation failure , Recurrent pregnancy loss have benefited from genomic fertility analysis. It has helped me a lot in taking crucial decisions, planning my treatment protocols and counseling such patients...Dr Anuradha is very approachable and always available to discuss the results.
Dr. Aradhya Achuri
MBBS, MS (ObGyn) Infertility specialist, Reproductive endocrinologist
Apollo Fertility, Hyderabad
Genetech has been doing exemplary service in the field of genetics. My patients always return happy and satisfied after attending genetic counseling at GeneTech. Experts at GeneTech are thorough professionals and help us understand latest developments in genetics. I think we gynaecologists should be utilizing their services extensively to help couples produce healthy children - Dr. Kameswari K, Senior Gynecologist, Sai Anurag Hospital, Hyderabad
Dr. K. Kameswari
MBBS, MD (ObGyn)
Sai Anurag Hospital, Hyderabad
I have known Dr. Anuradha and GeneTech for more than 20 yrs. She has always been on cutting edge of genetics and always made innovations to help Indian women and thier families. She has customised what is available globally, to suit our requirements. She is always available on phone. Ask a question -- this is the problem I have, is there a genetic element to it, can anything be done? -- I always would get a solution or a way out.
Dr. V. Padmaja
MBBS, MD (ObGyn)
Dr. Padmaja IVF Clinic, Vijayawada
GeneAndro test designed by GeneTech, is able to give us an idea of genetic causes for male infertility in patients where conventional reports like karotyping or Y chromosome micro deletions are normal. With the help of GeneAndro, we are not only able to identify root cause in most of our male infertility patients, we are also now able to confidently counsel our patients towards patient tailored treatment options.
Dr. Karthikeyan
MBBs, MS (Gen Sur), MCH (URO), MRCS Andrologist
Apollo Fertility, Chennai
Publications
View all
GeneTech consistently publishes research findings, case reports and review articles in reputed peer reviewed international and national journals, chapters in medical books and ART manuals, society magazines and newspapers.
View all

Pharmacogenomics – Inherited thrombophilia

Original article Genetic markers for inherited thrombophilia in Indian Population in the Journal of Maternal and Fetal Medicine, (2022).

Pharmacogenomics – Male infertility

Case Report on Favourable outcome with r-FSH treatment and FSHR gene variant in Fertility Science and Research (2021).

PGT for Clinicians

Chapter on basics and clinical applications of PGT in ART in the book Fertility Update (2024).

OncoFertility in clinical practice

Chapter on Femilial Cancer Genetics in the book Oncofertility-clinical Practice and Implementation Challenges (2025).

Genetic Counselling for PGT-M

Review article on Genetic Counseling for PGT-M in Frotiers of Reproductive Healthcare (2023).

PGT-M for ART

Chapter on PGT-M in the Manual of Assisted Reproductive Technologies and Laboratory Sciences- 2nd Edition (2025).

JHRS Original Article

Original article on Response to Controlled Ovarian Stimulation and Genetic associations in Indian women in JHRS (2023).

Personalised ART

Chapter on Genomic Fertility Analysis by GeneFemina & GeneAndro in the Manual of Assisted Reproductive Technologies and Laboratory 2nd Edition (2025).

Evidence for Improved ART Success

Original article Improved ART success with GeneFemina in Fertility Science and Research 2023

HealthBiz Insight Cover

HealthBIz Insight May 2017 issue, Diagnostics special edition covered industrial trends.
News & Events
View all
Latest guest lectures, panel discussions, event participation, community engagement in healthcare genomics, awards and accreditations and research developments in other fields.
View all

EIFM Yashoda Hospital

Dr. Anuradha Udumudi was invited panellist and chairperson at EIFM (Excellence in Fetal Medicine) annual 2026 conference conducted by Yashoda hospital Fetal Medicine unit. She participated as an expert in medical genetics and elucidated the genomics of fetal renal and gastro-intestinal anomalies.

KOGS (Kakinada Obstetrics and Gynecology Society)

Lecture by Dr. Anuradha Udumudi on “Latest Genomics for Obstetricians and Infertility practice” at KOGS (Kakinada Obstetrics and Gynecology Society) Annual Election and CME event at Kakinada, AP. Around 60 medical practitioners attended the CME and interacted with expert speaker who addressed all the queries.

Chief guest at Aurora's Degree collage, The DNA dialogue

Aurora's Degree and PG College organised a premier scientific talk, THE DNA DIALOG, focusing on Genomic Innovations and insights on 19th Feb 2026 at Bhaskara Auditorium BM Birla Science Center, Hyderabad. More than 250 undergraduate students from biotech, biological sciences attended the event. Dr. Anuradha Udumudi, Director GeneTech along with Padmasri Dr. Thangaraj, CSIR Bhatnagar Fellow CCMB, Dr. G. Sumalatha, BOS department of Genetics, Osmania University, delivered lectures and interacted with students sharing their experience and giving direction and advice to students of life sciences. The event was covered well by local media.

IRPLF National CME 2025

Invited Speaker and Chairperson at Indian Recurrent Loss Foundation (IRPLF) National CME (Delhi) on 14 Dec 2025.

Yuva Isar 2025

Invited speaker at Genetics Workshop at YUVA ISAR 2025 conference in Chennai on 13th June 2025.

Reproductive Health Master class

On Demand Webinar: Reproductive Health Master class organised by Thermofisher.

Chief Guest 9M CME

Guest lecture by Dr. Anuradha Udumudi on Genomic analysis and Pregnancy management for ObGyn at CME organised by 9M Fertility in Hyderabad.

Participation in TCOG Conference

Participated by putting up a stall, delivering a lecture and participation in multiple panel discussions

Key Note Address ISOPARB

Key Note Adress by Dr. Anuradha Udumudi at 40th annual national conference ISOPARB at NRI Medical College, Vijayawada on 16th Feb 2025.

MOU with London IVF

London IVF entered into an agreement with GeneTech to offer personalised fertility treatment to patients using GeneTech’s specialised genetic services.

YourGene KOL meeting 2023

Lecture at Key opinion leaders meeting organised by YourGene and Thermofisher on Non-Invasive Prenatal Testing (NIPT).

HOPE hospital CME 2023

Lecture to pediatricians and neonatologists of Latest advancements in genetic technologies and application in

EndoFertility 2023

Panel discussion on Recurrent pregnancy loss: Connecting dots between endocrinology and genetics at Concepts to

Maatrika 2023

Genetics of Recurrent pregnancy loss: A lecture by Dr. Anuradha Udumudi at Maatrika 2023.

MSART 2023 Malaysia

Distinguished international speaker at the annual conference of Malaysian Society of Assisted Reproductive Technology

FERTIVISION 2022

Participated by putting up a stall at IFS national conference in Hyderabad visited by more than 500 infertility specialists.
Videos
View all
GeneTech produces educational videos for benefit of patients and physicians. Here are some of such videos. Also included are videos delivered by our founder at various national and international events.
View all

Genetic Counseling – Commentary by GeneTech medical genetics team

Elaborate explanation of genetic counselling for different variety of cases

Genetic Counselling – An overview

An overview of Genetic Counselling explained by Dr. Anuradha Udumudi detailing benefits to families seeking advice and help.

Carrier Screening for Couple

Carrier Screening for couple and prevention of genetic disorders in children.

Effects of Close Relative Marriages on Offspring

Dr. Anuradha Udumudi explains effects of close relative marriages and prevention of genetic disorders in children in an interview for Bhava

Evidence based treatment for infertility

Root-cause genetic diagnosis, and evidence based personalised treatment using GeneFeminaTM and GeneAndroTM

Genetics of Autism

Genetic basis of Autism and ADHD

Infertility Genetic tests and Personalised treatment

Dr. Anuradha Udumudi explains infertility management by genegenetic tests in an interview for BhavaniHD channel

Prenatal Sampling for Genetic Diagnosis

Know more about prenatal sampling procedures during pregnancy like Amniocentesis and CVS biopsy.

Reproductive Health Talk

Genomic technological developments and transformation of genetic diagnosis and management of reproductive health

What is a genetic Disorder?

All about genetic disorders, diagnosis and prevention
Customer Stories
View all
Discover how genomics testing empowers our clients in medical, agricultural, and animal sectors. From finding root cause of infertility to enhancing crop yields, explore the real-world impact of our innovative services.

Nutrition Tips for Growing Children

Mindful eating involves paying attention to the experience of eating and drinking. It encourages individuals to slow down..

The Importance of Preventive Health Care

Mindful eating involves paying attention to the experience of eating and drinking. It encourages individuals to slow down..

Healthy Snacking Options for Busy Lives

Mindful eating involves paying attention to the experience of eating and drinking. It encourages individuals to slow down..

The Role of Hydration in Health

Mindful eating involves paying attention to the experience of eating and drinking. It encourages individuals to slow down..

Effective Stress Management Techniques

Mindful eating involves paying attention to the experience of eating and drinking. It encourages individuals to slow down..

The Importance of Sleep for Health

Mindful eating involves paying attention to the experience of eating and drinking. It encourages individuals to slow down..

Understanding Mental Health Awareness

Mindful eating involves paying attention to the experience of eating and drinking. It encourages individuals to slow down..

The Benefits of Regular Exercise

Mindful eating involves paying attention to the experience of eating and drinking. It encourages individuals to slow down..

Healthy Eating Tips for a Balanced Diet

Mindful eating involves paying attention to the experience of eating and drinking. It encourages individuals to slow down..

Frequently asked questions

What is Genetic Testing?
What are the uses of Genetic Testing?
What are the types of Genetic testing?
Are all genetic disorders hereditary?
Join our newsletter
We offer subscription to our knowledge-base to physicians of various specialties. Please enter your email and click the subscribe button.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Subscribe now
Join the mailing list to subscribe to GeneTech knowledge base
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.